Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

GRANDE PHARMACIE NOUVELLE : revenue, balance sheet and financial ratios

GRANDE PHARMACIE NOUVELLE is a French company founded 7 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in TOURNAN-EN-BRIE (77220), this company of category PME shows in 2021 a net income positive of 115 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - GRANDE PHARMACIE NOUVELLE (SIREN 842693293)
Indicator 2021 2020 2019
Revenue N/C N/C N/C
Net income 114 831 € 232 995 € -145 174 €
EBITDA N/C N/C N/C
Net margin N/C N/C N/C

Revenue and income statement

In 2021, GRANDE PHARMACIE NOUVELLE generates positive net income of 115 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2021) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

114 831 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 1073%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 7%. Low autonomy: the company heavily depends on external financing (banks, suppliers).

Debt ratio (2021) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

1072.595%

Financial autonomy (2021) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

6.855%

Asset age ratio (2021) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

45.0%

Solvency indicators evolution
GRANDE PHARMACIE NOUVELLE

Sector positioning

Debt ratio
1072.6 2021
2019
2020
2021
Q1: 29.03
Med: 85.54
Q3: 208.44
Watch +50 pts over 3 years

In 2021, the debt ratio of GRANDE PHARMACIE NOUVELLE (1072.60) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.

Financial autonomy
6.86% 2021
2019
2020
2021
Q1: 25.88%
Med: 44.4%
Q3: 64.18%
Watch

In 2021, the financial autonomy of GRANDE PHARMACIE NOUVELLE (6.9%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 128.40. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2021) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

128.398

Liquidity indicators evolution
GRANDE PHARMACIE NOUVELLE

Sector positioning

Liquidity ratio
128.4 2021
2019
2020
2021
Q1: 139.19
Med: 190.69
Q3: 259.61
Watch +8 pts over 3 years

In 2021, the liquidity ratio of GRANDE PHARMACIE NOUVELLE (128.40) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Positioning of GRANDE PHARMACIE NOUVELLE in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 220 transactions of similar company sales in 2021, the value of GRANDE PHARMACIE NOUVELLE is estimated at 1 317 159 € (range 846 939€ - 2 034 597€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2021
220 transactions
846k€ 1317k€ 2034k€
1 317 159 € Range: 846 939€ - 2 034 597€
NAF 5 année 2021

Valuation method used

Net Income Multiple
114 831 € × 11.5x = 1 317 159 €
Range: 846 940€ - 2 034 597€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare GRANDE PHARMACIE NOUVELLE with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about GRANDE PHARMACIE NOUVELLE

What is the revenue of GRANDE PHARMACIE NOUVELLE ?

The revenue of GRANDE PHARMACIE NOUVELLE is not publicly disclosed (confidential accounts filed with INPI).

Is GRANDE PHARMACIE NOUVELLE profitable?

Yes, GRANDE PHARMACIE NOUVELLE generated a net profit of 115 k€ in 2021.

Where is the headquarters of GRANDE PHARMACIE NOUVELLE ?

The headquarters of GRANDE PHARMACIE NOUVELLE is located in TOURNAN-EN-BRIE (77220), in the department Seine-et-Marne.

Where to find the tax return of GRANDE PHARMACIE NOUVELLE ?

The tax return of GRANDE PHARMACIE NOUVELLE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does GRANDE PHARMACIE NOUVELLE operate?

GRANDE PHARMACIE NOUVELLE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.